|
1
|
World Health Organization (WHO):
Coronavirus disease (COVID-19) outbreak situation. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Accessed June 20, 2020.
|
|
2
|
Parvez MK: Emerging and re-emerging viral
diseases: Controls and preventions. In: Microbial pathogens and
strategies for combating them science, technology and education.
Méndez-Vilas A (ed). Formatex Research Center, Badajoz, 2013.
|
|
3
|
Parvez MK and Parveen S: Evolution and
emergence of pathogenic viruses: Past, present, and future.
Intervirology. 60:1–7. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wever PC and van Bergen L: Death from 1918
pandemic influenza during the first world war: A perspective from
personal and anecdotal evidence. Influenza Other Respir Viruses.
8:538–546. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
International Committee on Taxonomy of
Viruses (ICTV): Virus taxonomy: The classification and nomenclature
of viruses. https://talk.ictvonline.org/ictv-reports/ictv_online_report/.
Accessed June 20, 2020.
|
|
6
|
Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L,
Xu T, Jiang YZ, Xiong Y, Li YJ, Li XW, et al: Identification of a
novel coronavirus causing severe pneumonia in human: A descriptive
study. Chin Med J (Engl). 133:1015–1024. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
World Health Organization (WHO):
Director-General's opening remarks at the media briefing on
COVID-19. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-18-march-2020.
Accessed June 20, 2020.
|
|
8
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kissler SM, Tedijanto C, Goldstein E, Grad
YH and Lipsitch M: Projecting the transmission dynamics of
SARS-CoV-2 through the postpandemic period. Science. 368:860–868.
2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bauch CT and Oraby T: Assessing the
pandemic potential of MERS-CoV. Lancet. 382:662–664.
2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chen Y, Liu Q and Guo D: Emerging
coronaviruses: Genome structure, replication, and pathogenesis. J
Med Virol. 92:418–423. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen B, Liang H, Yuan X, Hu Y, Xu M, Zhao
Y, Zhang B, Tian F and Zhu X: Roles of meteorological conditions in
COVID-19 transmission on a worldwide scale. medRxiv: https://doi.org/10.1101/2020.03.16.20037168.
|
|
13
|
Cárdenas-Conejo Y, Liñan-Rico A,
García-Rodríguez DA, Centeno-Leija S and Serrano-Posada H: An
exclusive 42 amino acid signature in pp1ab protein provides
insights into the evolutive history of the 2019 novel
human-pathogenic coronavirus (SARS-CoV-2). J Med Virol. 92:688–692.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song
ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al: A new coronavirus
associated with human respiratory disease in China. Nature.
579:265–269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Coronaviridae Study Group of the
International Committee on Taxonomy of Viruses: The species severe
acute respiratory syndrome-related coronavirus: Classifying
2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5: 536-544,
2020.
|
|
16
|
Kumar S, Maurya VK, Prasad AK, Bhatt MLB
and Saxena SK: Structural, glycosylation and antigenic variation
between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus
(SARS-CoV). Virus Disease. 31:13–21. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chan JF, Kok KH, Zhu Z, Chu H, Kai-Wang K,
Yuan S and Yuen KY: Genomic characterization of the 2019 novel
human-pathogenic coronavirus isolated from a patient with atypical
pneumonia after visiting Wuhan. Emerg Microbes Infect. 9:221–236.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Walls AC, Park YJ, Tortorici MA, Wall A,
McGuire AT and Veesler D: Structure, function, and antigenicity of
the SARS-CoV-2 spike glycoprotein. Cell. 181:281–292.e286.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Coutard B, Valle C, de Lamballerie X,
Canard B, Seidah NG and Decroly E: The spike glycoprotein of the
new coronavirus 2019-nCoV contains a furin-like cleavage site
absent in CoV of the same clade. Antiviral Res.
176(104742)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wan Y, Shang J, Graham R, Baric RS and Li
F: Receptor recognition by the novel coronavirus from Wuhan: An
analysis based on decade-long structural studies of SARS
coronavirus. J Virol. 94:e00127–e00120. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wrapp D, Wang N, Corbett KS, Goldsmith JA,
Hsieh CL, Abiona O, Graham BS and McLellan JS: Cryo-EM structure of
the 2019-nCoV spike in the prefusion conformation. Science.
367:1260–1263. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Leung DT, Tam FC, Ma CH, Chan PK, Cheung
JL, Niu H, Tam JS and Lim PL: Antibody response of patients with
severe acute respiratory syndrome (SARS) targets the viral
nucleocapsid. J Infect Dis. 190:379–386. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
European Center for Disease Prevention and
Control (ECDC): COVID-19 situation update worldwide, as of 6 July
2020. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases.
Accessed June 20, 2020.
|
|
24
|
Schoeman D and Fielding BC: Coronavirus
envelope protein: Current knowledge. Virol J. 16(69)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kakodkar P, Kaka N and Baig MN: A
comprehensive literature review on the clinical presentation, and
management of the pandemic coronavirus disease 2019 (COVID-19).
Cureus. 12(e7560)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li Y and Xia L: Coronavirus disease 2019
(COVID-19): Role of chest CT in diagnosis and management. AJR Am J
Roentgenol. 214:1280–1286. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wong HYF, Lam HYS, Fong AH, Leung ST, Chin
TW, Lo CS, Lui MM, Lee JC, Chiu KW, Chung T, et al:
Frequency and distribution of chest radiographic findings in
COVID-19 positive patients. Radiology 2011: 60, 2019 (Online ahead
of print).
|
|
28
|
Ge XY, Li JL, Yang XL, Chmura AA, Zhu G,
Epstein JH, Mazet JK, Hu B, Zhang W, Peng C, et al: Isolation and
characterization of a bat SARS-like coronavirus that uses the ACE2
receptor. Nature. 503:535–538. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li W, Moore MJ, Vasilieva N, Sui J, Wong
SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough
TC, et al: Angiotensin-converting enzyme 2 is a functional receptor
for the SARS coronavirus. Nature. 426:450–454. 2003.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hamming I, Timens W, Bulthuis ML, Lely AT,
Navis G and van Goor H: Tissue distribution of ACE2 protein, the
functional receptor for SARS coronavirus. A first step in
understanding SARS pathogenesis. J Pathol. 203:631–637.
2004.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fang L, Karakiulakis G and Roth M: Are
patients with hypertension and diabetes mellitus at increased risk
for COVID-19 infection? Lancet Respir Med. 8(e21)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Totura AL and Baric RS: SARS coronavirus
pathogenesis: Host innate immune responses and viral antagonism of
interferon. Curr Opin Virol. 2:264–275. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Adams DH and Hubscher SG: Systemic viral
infections and collateral damage in the liver. Am J Pathol.
168:1057–1059. 2006.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gu J, Han B and Wang J: COVID-19:
Gastrointestinal manifestations and potential fecal-oral
transmission. Gastroenterology. 158:1518–1519. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang C, Shi L and Wang FS: Liver injury
in COVID-19: Management and challenges. Lancet Gastroenterol
Hepatol. 5:428–430. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J,
Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics
of 138 hospitalized patients with 2019 novel coronavirus-infected
pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He
JX, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics
of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720.
2020.
|
|
38
|
Shi H, Han X, Jiang N, Cao Y, Alwalid O,
Gu J, Fan Y and Zheng C: Radiological findings from 81 patients
with COVID-19 pneumonia in Wuhan, China: A descriptive study.
Lancet Infect Dis. 20:425–434. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Qi F, Qian S, Zhang S and Zhang Z: Single
cell RNA sequencing of 13 human tissues identify cell types and
receptors of human coronaviruses. Biochem Biophys Res Commun.
526:135–140. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu
L, Bi Z and Zhao Y: Prevalence and impact of cardiovascular
metabolic diseases on COVID-19 in China. Clin Res Cardiol.
109:531–538. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Long B, Brady WJ, Koyfman A and Gottlieb
M: Cardiovascular complications in COVID-19. Am J Emerg Med.
38:1504–1507. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lippi G and Plebani M: Laboratory
abnormalities in patients with COVID-2019 infection. Clin Chem Lab
Med. 58:1131–1134. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Li JW, Han TW, Woodward M, Anderson CS,
Zhou H, Chen YD and Neal B: The impact of 2019 novel coronavirus on
heart injury: A systemic review and meta-analysis. Prog Cardiovasc
Dis: April 16, 2020 (Epub ahead of print).
|
|
44
|
Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang
ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YL, et al: Isolation
and characterization of viruses related to the SARS coronavirus
from animals in southern China. Science. 302:276–278.
2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Li W, Shi Z, Yu M, Ren W, Smith C, Epstein
JH, Wang H, Crameri G, Hu Z, Zhang H, et al: Bats are natural
reservoirs of SARS-like coronaviruses. Science. 310:676–679.
2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Andersen KG, Rambaut A, Lipkin WI, Holmes
EC and Garry RF: The proximal origin of SARS-CoV-2. Nat Med.
26:450–452. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Corman VM, Eckerle I, Bleicker T, Zaki A,
Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M,
Bestebroer TM, et al: Detection of a novel human coronavirus by
real-time reverse-transcription polymerase chain reaction. Euro
Surveill. 17(20285)2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Banerjee A, Kulcsar K, Misra V, Frieman M
and Mossman K: Bats and Coronaviruses. Viruses.
11(41)2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Reusken CB, Raj VS, Koopmans MP and
Haagmans BL: Cross host transmission in the emergence of MERS
coronavirus. Curr Opin Virol. 16:55–62. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Laguipo A: Tiger with SARS-CoV-2 infection
demostrates reverse zoonosis. News-Medical, 2020. https://www.news-medical.net/news/20200406/Tiger-with-SARS-CoV-2-infection-demostrates-reverse-zoonosis.aspx.
Accessed April 6, 2020.
|
|
51
|
Zhang W, Du RH, Li B, Zheng XS, Yang XL,
Hu B, Wang YY, Xiao GF, Yan B, Shi ZL and Zhou P: Molecular and
serological investigation of 2019-nCoV infected patients:
Implication of multiple shedding routes. Emerg Microbes Infect.
9:386–389. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Xu Y, Li X, Zhu B, Liang H, Fang C, Gong
Y, Guo Q, Sun X, Zhao D, Shen J, et al: Characteristics of
pediatric SARS-CoV-2 infection and potential evidence for
persistent fecal viral shedding. Nat Med. 26:502–505.
2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Holshue ML, DeBolt C, Lindquist S, Lofy
KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural
A, et al: First case of 2019 novel coronavirus in the United
States. N Engl J Med. 382:929–936. 2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Tang A, Tong ZD, Wang HL, Dai YX, Li KF,
Liu JN, Wu WJ, Yuan C, Yu ML, Li P and Yan JB: Detection of novel
coronavirus by RT-PCR in stool specimen from asymptomatic child,
China. Emerg Infect Dis. 26:1337–1339. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Young BE, Ong SWX, Kalimuddin S, Low JG,
Tan SY, Loh J, Ng OT, Marimuthu K, Ang LW, Mak TM, et al:
Epidemiologic features and clinical course of patients infected
with SARS-CoV-2 in Singapore. JAMA. 323:1488–1494. 2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
van Doremalen N, Bushmaker T, Morris DH,
Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL,
Thornburg NJ, Gerber SI, et al: Aerosol and surface stability of
SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med.
382:1564–1567. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Jin YH, Cai L, Cheng ZS, Cheng H, Deng T,
Fan YP, Fang C, Huang D, Huang LQ, Huang Q, et al: A rapid advice
guideline for the diagnosis and treatment of 2019 novel coronavirus
(2019-nCoV) infected pneumonia (standard version). Mil Med Res.
7(4)2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Borba MGS, Val FFA, Sampaio VS, Alexandre
MAA, Melo GC, Brito M, Mourão MPG, Brito-Sousa JD, Baía-da-Silva D,
Guerra MVF, et al: Chloroquine diphosphate in two different
dosages as adjunctive therapy of hospitalized patients with severe
respiratory syndrome in the context of coronavirus (SARS-CoV-2)
infection: Preliminary safety results of a randomized,
double-blinded, phase IIb clinical trial (CloroCovid-19 Study).
medRxiv: doi: https://doi.org/10.1101/2020.04.07.20056424.
|
|
59
|
Chorin E, Dai M, Shulman E, Wadhwani L,
RoiBar-Cohen, Barbhaiya C, Aizer A, Holmes D, Bernstein S, Spinelli
M, et al: The QT interval in patients with SARS-CoV-2
infection treated with hydroxychloroquine/azithromycin. medRxiv:
doi: https://doi.org/10.1101/2020.04.02.20047050.
|
|
60
|
Roden DM, Harrington RA, Poppas A and
Russo AM: Considerations for drug interactions on QTc in
exploratory COVID-19 (coronavirus disease 2019) treatment. Heart
Rhythm. 17:e231–e232. 2020.
|
|
61
|
Huang J, Song W, Huang H and Sun Q:
Pharmacological therapeutics targeting RNA-dependent RNA
polymerase, proteinase and spike protein: From mechanistic studies
to clinical trials for COVID-19. J Clin Med. 9(1131)2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Center for Disease control (CDC):
Information for Clinicians on Investigational Therapeutics for
Patients with COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html.
Accessed April 25, 2020.
|
|
63
|
Akst J: COVID-19 Vaccine Frontrunners. The
scientist, 2020. https://www.the-scientist.com/news-opinion/covid-19-vaccine-frontrunners-67382.
Accessed June 20, 2020.
|
|
64
|
Zhang C, Chen C, Shen W, Tang F, Lei H,
Xie Y, Cao Z, Tang K, Bai J, Xiao L, et al: Impact of population
movement on the spread of 2019-nCoV in China. Emerg Microbes
Infect. 9:988–990. 2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Chinazzi M, Davis JT, Ajelli M, Gioannini
C, Litvinova M, Merler S, Piontti APY, Mu K, Rossi L, Sun K, et al:
The effect of travel restrictions on the spread of the 2019 novel
coronavirus (COVID-19) outbreak. Science. 368:395–400.
2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Anderson RM, Fraser C, Ghani AC, Donnelly
CA, Riley S, Ferguson NM, Leung GM, Lam TH and Hedley AJ:
Epidemiology, transmission dynamics and control of SARS: The
2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci.
359:1091–1105. 2004.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Hufnagel L, Brockmann D and Geisel T:
Forecast and control of epidemics in a globalized world. Proc Natl
Acad Sci USA. 101:15124–15129. 2004.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Eletreby R, Zhuang Y, Carley KM, Yagan O
and Poor HV: The effects of evolutionary adaptations on spreading
processes in complex networks. Proc Natl Acad Sci USA.
117:5664–5670. 2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Zhou J and McCandlish DM: Minimum
epistasis interpolation for sequence-function relationships. Nat
Commun. 11(1782)2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Parvez MK: Gastrointestinal and
hepatobiliary manifestations of coronavirus disease-19: Potential
implications for healthcare resource-deficient countries.
Gastroenterol Heptal Lett. 2:7–11. 2020.
|
